Propanc Successfully Completes Low Dose Group for GLP-Compliant 28-Day Repeat-Dose Toxicity Study Feb 14, 2017
Propanc Receives Allowance of Key Patent Application for Method of Treating Solid Tumors in the US Jan 11, 2017
Propanc Health Group Corporation to Webcast, Live, at VirtualInvestorConferences.com December 1 Nov 22, 2016
Propanc Files Application for Orphan Medicinal Product Designation in the EU for Ovarian Cancer Nov 1, 2016